Results 1 to 10 of about 556,132 (392)

Identification of a sub-group of critically ill patients with high risk of intensive care unit-acquired infections and poor clinical course using a transcriptomic score

open access: yesCritical Care, 2023
Background The development of stratification tools based on the assessment of circulating mRNA of genes involved in the immune response is constrained by the heterogeneity of septic patients.
Maxime Bodinier   +12 more
doaj   +1 more source

Recombinant human interleukin-7 reverses T cell exhaustion ex vivo in critically ill COVID-19 patients

open access: yesAnnals of Intensive Care, 2022
Background Lymphopenia is a hallmark of severe coronavirus disease 19 (COVID-19). Similar alterations have been described in bacterial sepsis and therapeutic strategies targeting T cell function such as recombinant human interleukin 7 (rhIL-7) have been ...
Frank Bidar   +17 more
doaj   +1 more source

A stratification strategy to predict secondary infection in critical illness-induced immune dysfunction: the REALIST score

open access: yesAnnals of Intensive Care, 2022
Background Although multiple individual immune parameters have been demonstrated to predict the occurrence of secondary infection after critical illness, significant questions remain with regards to the selection, timing and clinical utility of such ...
Jan-Alexis Tremblay   +12 more
doaj   +1 more source

Interferon gamma as an immune modulating adjunct therapy for invasive mucormycosis after severe burn – A case report

open access: yesFrontiers in Immunology, 2022
BackgroundMucormycosis is a deadly fungal infection that mainly affects severely immunocompromised patients. We report herein the case of a previously immunocompetent adult woman who developed invasive cutaneous mucormycosis after severe burn injuries ...
Dina M. Tawfik   +22 more
doaj   +1 more source

Macromolecular Immunosuppressants [PDF]

open access: yesBiotechnology Journal, 2005
AbstractRecombinant immunosuppressants have come of age and represent a significant class of quite diverse drugs. They target extracellular molecules, and either label or inhibit them. Those targets are soluble factors or membrane proteins almost all of which are components of a very complex molecular network of communication and amplification. Notably,
Theo, Dingermann, Ilse, Zündorf
openaire   +2 more sources

Characterization of Circulating IL-10-Producing Cells in Septic Shock Patients: A Proof of Concept Study

open access: yesFrontiers in Immunology, 2021
Sepsis is a worldwide health priority characterized by the occurrence of severe immunosuppression associated with increased risk of death and secondary infections.
Astrid Fabri   +18 more
doaj   +1 more source

Mortality Prediction in Sepsis With an Immune-Related Transcriptomics Signature: A Multi-Cohort Analysis

open access: yesFrontiers in Medicine, 2022
BackgroundNovel biomarkers are needed to progress toward individualized patient care in sepsis. The immune profiling panel (IPP) prototype has been designed as a fully-automated multiplex tool measuring expression levels of 26 genes in sepsis patients to
Louis Kreitmann   +25 more
doaj   +1 more source

TCR activation mimics CD127lowPD-1high phenotype and functional alterations of T lymphocytes from septic shock patients

open access: yesCritical Care, 2019
Background Sepsis is the leading cause of mortality for critically ill patients worldwide. Patients develop T lymphocyte dysfunctions leading to T-cell exhaustion associated with increased risk of death.
Julie Mouillaux   +10 more
doaj   +1 more source

A novel virotherapy encoding human interleukin-7 improves ex vivo T lymphocyte functions in immunosuppressed patients with septic shock and critically ill COVID-19

open access: yesFrontiers in Immunology, 2022
A majority of patients with sepsis surviving the first days in intensive care units (ICU) enter a state of immunosuppression contributing to their worsening.
Morgane Crausaz   +11 more
doaj   +1 more source

Immunosuppressants

open access: yesJournal of the California Dental Association, 2008
This paper provides a brief introduction to some of the common immunosuppressants used in oral medicine, the prevention and treatment of oral adverse effects of immunosuppressants, and considerations for dental treatment in patients taking immunosuppressants.
Nita, Chainani-Wu, Timothy C, Wu
openaire   +2 more sources

Home - About - Disclaimer - Privacy